These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
7. A study on the incidence of ABL gene deletion on derivative chromosome 9 in chronic myelogenous leukemia by interphase fluorescence in situ hybridization and its association with disease progression. Lee DS; Lee YS; Yun YS; Kim YR; Jeong SS; Lee YK; She CJ; Yoon SS; Shin HR; Kim Y; Cho HI Genes Chromosomes Cancer; 2003 Jul; 37(3):291-9. PubMed ID: 12759927 [TBL] [Abstract][Full Text] [Related]
8. Detection of the BCR/ABL fusion gene in chronic myeloid leukemia by RNA polymerase chain reaction. Qian XH; Yang AD; Fei HB; Wang CC J Tongji Med Univ; 1993; 13(3):129-33. PubMed ID: 8295258 [TBL] [Abstract][Full Text] [Related]
9. Establishment of a cell line with variant BCR/ABL breakpoint expressing P180BCR/ABL from late-appearing Philadelphia-positive acute biphenotypic leukemia. Inokuchi K; Shinohara T; Futaki M; Hanawa H; Tanosaki S; Yamaguchi H; Nomura T; Dan K Genes Chromosomes Cancer; 1998 Nov; 23(3):227-38. PubMed ID: 9790503 [TBL] [Abstract][Full Text] [Related]
10. BCR-ABL tyrosine kinase activity regulates the expression of multiple genes implicated in the pathogenesis of chronic myeloid leukemia. Deininger MW; Vieira S; Mendiola R; Schultheis B; Goldman JM; Melo JV Cancer Res; 2000 Apr; 60(7):2049-55. PubMed ID: 10766197 [TBL] [Abstract][Full Text] [Related]
11. Analysis of the clinico-hematological relevance of the breakpoint location within M-BCR in chronic myeloid leukemia. Bennour A; Ouahchi I; Achour B; Zaier M; Youssef YB; Khelif A; Saad A; Sennana H Med Oncol; 2013 Mar; 30(1):348. PubMed ID: 23269583 [TBL] [Abstract][Full Text] [Related]
13. [Kinetics of proliferation, differentiation and transcription of genes regulating apoptosis in cultured human BCR/ABL+ Ph+-cells]. Akhlynina TV; Gerasimova LP; Sarkisian GP; Borovkova TV; Dukhovenskaia EA; Manakova TE; Naĭdenova NM; Timofeev AM; Grineva NI Tsitologiia; 2007; 49(10):889-900. PubMed ID: 18074781 [TBL] [Abstract][Full Text] [Related]
14. Specific killing of Ph+ chronic myeloid leukemia cells by a lentiviral vector-delivered anti-bcr/abl small hairpin RNA. Li MJ; McMahon R; Snyder DS; Yee JK; Rossi JJ Oligonucleotides; 2003; 13(5):401-9. PubMed ID: 15000831 [TBL] [Abstract][Full Text] [Related]
15. BCR and BCR-ABL regulation during myeloid differentiation in healthy donors and in chronic phase/blast crisis CML patients. Marega M; Piazza RG; Pirola A; Redaelli S; Mogavero A; Iacobucci I; Meneghetti I; Parma M; Pogliani EM; Gambacorti-Passerini C Leukemia; 2010 Aug; 24(8):1445-9. PubMed ID: 20520635 [TBL] [Abstract][Full Text] [Related]
16. Leukemia cell lines: in vitro models for the study of Philadelphia chromosome-positive leukemia. Drexler HG; MacLeod RA; Uphoff CC Leuk Res; 1999 Mar; 23(3):207-15. PubMed ID: 10071072 [TBL] [Abstract][Full Text] [Related]
17. Molecular biology of chronic myeloid leukemia. Maru Y Int J Hematol; 2001 Apr; 73(3):308-22. PubMed ID: 11345196 [TBL] [Abstract][Full Text] [Related]
19. [Research advance on molecular genetics of CML blast crisis]. Zhu HQ; Zhang S; Liu XL Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2008 Feb; 16(1):217-21. PubMed ID: 18315935 [TBL] [Abstract][Full Text] [Related]
20. [Overexpression of Shp-2 is associated with the unlimited growth and apoptosis resistance of p210 bcr-abl-mediated chronic myeloid leukemia]. Zhu XZ; Yu YZ; Fang YM; Liang Y; Lü QH; Xu RZ Zhonghua Yi Xue Za Zhi; 2005 Jul; 85(27):1903-6. PubMed ID: 16255985 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]